MAPPING RECEPTOR-BINDING SITES IN INTERLEUKIN (IL)-1 RECEPTOR ANTAGONIST AND IL-1-BETA BY SITE-DIRECTED MUTAGENESIS - IDENTIFICATION OF A SINGLE-SITE IN IL-1RA AND 2 SITES IN IL-1-BETA
Rj. Evans et al., MAPPING RECEPTOR-BINDING SITES IN INTERLEUKIN (IL)-1 RECEPTOR ANTAGONIST AND IL-1-BETA BY SITE-DIRECTED MUTAGENESIS - IDENTIFICATION OF A SINGLE-SITE IN IL-1RA AND 2 SITES IN IL-1-BETA, The Journal of biological chemistry, 270(19), 1995, pp. 11477-11483
Interleukin-l receptor antagonist (IL-1ra), an IL-1 family member, bin
ds with high affinity to the type I IL-1 receptor (IL-1RI), blocking I
L-1 binding but not inducing an IL-l-like response. Extensive site-dir
ected mutagenesis has been used to identify residues in IL-1ra and IL-
1 beta involved in binding to IL-1RI. These analyses have revealed the
presence of two discrete receptor binding sites on IL-1 beta. Only on
e of these sites is present on IL-1ra, consisting of residues Trp-16,
Gln-20, Tyr-34, Gln-36, and Tyr-147. Interestingly, the absent second
site is at the location of the major structural difference between IL-
1 beta and IL-1 beta, which are otherwise structurally similar. The tw
o receptor binding sites on IL-1 beta are also present on IL-1 alpha.
Thus, it appears that the two IL-1 agonist molecules have two sites fo
r IL-1RI binding, and the homologous antagonist molecule, IL-1ra, has
only one. Based on these observations, a hypothesis is presented to ac
count for the difference in activity between the agonist and antagonis
t proteins. It is proposed that the presence of the two receptor bindi
ng sites may be necessary for agonist activity.